Orkambi Study On Children Age 6-12 With DDF508: Cystic Fibrosis Treatment
Results are in from a 24-week study of Orkambi (lumacaftor/ivacaftor – a medication used in cystic fibrosis treatment) in 58 children […]
Trial results of Ivacaftor in Cystic Fibrosis children ages 2-5
Results are out from a two part study involving children ages 2-5 with at least one gating mutation trying Ivacaftor […]